How a joined-up development strategy pays off for early-stage biotechs
Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.
Related Insights
Blog
Focusing on value drivers to reduce risk in early-stage drug development
Jan 6, 2025
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Related Insights
Blog
Focusing on value drivers to reduce risk in early-stage drug development
Jan 6, 2025
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025